Rigel Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7665596034
USD
26.50
0.54 (2.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
391.48
3.29
-28.64
-13.62
30.37
34.03
Shareholder's Funds
391.48
3.29
-28.64
-13.62
30.37
34.03
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
52.91
59.97
60.29
40.58
29.81
28.44
Secured Loans
52.91
59.97
60.29
40.58
29.81
28.44
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-245.85
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
47.42
374.21
40.23
43.24
53.49
15.7
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
69.90
426.62
92.60
82.68
73.40
35.51
Current Liabilities
Trade Payables
7.19
3.34
7.14
22.51
3.79
3.71
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
99.24
63.30
53.27
65.21
63.55
40.84
Total Liabilities
560.62
493.21
117.22
134.28
167.33
110.38
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
1.27
0.60
2.73
13.59
26.44
34.25
Less: Accumulated Depreciation
0.32
0.26
1.70
10.81
14.55
13.68
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
0.95
0.34
1.03
2.79
11.89
20.57
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.06
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
1.82
1.44
3.06
0.64
0.97
0.82
Total Non-Current Assets
320.45
358.11
17.96
18.38
12.86
21.39
Current Assets Loans & Advances
Current Investments
114.38
20.57
24.15
33.75
106.08
26.95
Inventories
11.51
9.80
5.52
9.92
6.62
5.64
Sundry Debtors
51.76
41.62
30.55
40.32
15.47
15.97
Cash and Bank
40.58
56.75
32.79
24.46
18.89
30.37
Other Current Assets
218.22
128.74
93.01
108.44
147.06
78.94
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
240.17
135.10
99.27
115.90
154.47
88.98
Net Current Assets (Including Current Investments)
140.93
71.80
46.00
50.69
90.91
48.14
Total Current Assets Excluding Current Investments
240.17
135.10
99.27
115.90
154.47
88.98
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
560.62
493.21
117.22
134.28
167.33
110.38
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
52.91
59.97
60.29
40.58
29.81
28.44
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Rigel Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
391.48
10.97
380.51
3,468.64%
Shareholder's Funds
391.48
10.97
380.51
3,468.64%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
52.91
2.15
50.76
2,360.93%
Secured Loans
52.91
2.15
50.76
2,360.93%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-245.85
0
-245.85
0.00%
Other Long Term Liabilities
47.42
3.59
43.83
1,220.89%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
69.90
3.59
66.31
1,847.08%
Current Liabilities
Trade Payables
7.19
2.86
4.33
151.40%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
99.24
7.74
91.50
1,182.17%
Total Liabilities
560.62
22.31
538.31
2,412.86%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
1.27
17.65
-16.38
-92.80%
Less: Accumulated Depreciation
0.32
10.88
-10.56
-97.06%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
0.95
6.77
-5.82
-85.97%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.06
0
0.06
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
1.82
0.31
1.51
487.10%
Total Non-Current Assets
320.45
7.08
313.37
4,426.13%
Current Assets Loans & Advances
Current Investments
114.38
6.53
107.85
1,651.61%
Inventories
11.51
1.11
10.40
936.94%
Sundry Debtors
51.76
0
51.76
0.00%
Cash and Bank
40.58
6.59
33.99
515.78%
Other Current Assets
218.22
14.23
203.99
1,433.52%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
240.17
15.23
224.94
1,476.95%
Net Current Assets (Including Current Investments)
140.93
7.49
133.44
1,781.58%
Total Current Assets Excluding Current Investments
240.17
15.23
224.94
1,476.95%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
560.62
22.31
538.31
2,412.86%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
52.91
2.15
50.76
2,360.93%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period